Approval · Notice of Compliance 11473 · 2010
FLECAINIDE: Notice of Compliance 11473
Issued June 2, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11473
- Date
- June 2, 2010
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antiarrhythmic agent
- Canadian reference product
- TAMBOCOR (3M Pharmaceuticals, A Division Of 3M Canada Company)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLECAINIDE | 02275538 | Marketed |
| FLECAINIDE | 02275546 | Marketed |
Medicinal ingredients
- FLECAINIDE ACETATE 50 MG per TAB
- FLECAINIDE ACETATE 100 MG per TAB